Residential Care Software Revenue: Increased by 12%. ResMed Inc (NYSE:RMD) reported a strong quarter with an 11% revenue growth, driven by demand for sleep health and breathing health medical devices.

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

For the three months ended 30 September, ResMed reported an 11% increase in revenue to US$1,224.5 million. This was largely in line with consensus estimates for the period. Management advised that ...

Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at https://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD ...

Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE ...